These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19106731)

  • 1. Relative efficiency of the EQ-5D, HUI2, and HUI3 index scores in measuring health burden of chronic medical conditions in a population health survey in the United States.
    Luo N; Johnson JA; Shaw JW; Coons SJ
    Med Care; 2009 Jan; 47(1):53-60. PubMed ID: 19106731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon's indices.
    Bas Janssen MF; Birnie E; Bonsel GJ
    Qual Life Res; 2007 Jun; 16(5):895-904. PubMed ID: 17294285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three societally derived health-state classification values among older African Americans with depressive symptoms.
    Jutkowitz E; Pizzi L; Hess E; Suh DC; Gitlin LN
    Qual Life Res; 2013 Aug; 22(6):1491-8. PubMed ID: 22972437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample.
    Luo N; Ko Y; Johnson JA; Coons SJ
    Qual Life Res; 2009 Dec; 18(10):1377-85. PubMed ID: 19830593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.
    Luo N; Johnson JA; Shaw JW; Feeny D; Coons SJ
    Med Care; 2005 Nov; 43(11):1078-86. PubMed ID: 16224300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.
    Grutters JP; Joore MA; van der Horst F; Verschuure H; Dreschler WA; Anteunis LJ
    Qual Life Res; 2007 Oct; 16(8):1439-49. PubMed ID: 17647093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the psychometric properties of generic utility measures in multiple sclerosis.
    Kuspinar A; Mayo NE
    Pharmacoeconomics; 2014 Aug; 32(8):759-73. PubMed ID: 24846760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections.
    Kulpeng W; Sornsrivichai V; Chongsuvivatwong V; Rattanavipapong W; Leelahavarong P; Cairns J; Lubell Y; Teerawattananon Y
    BMC Pediatr; 2013 Aug; 13():122. PubMed ID: 23941314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease.
    Luo N; Chew LH; Fong KY; Koh DR; Ng SC; Yoon KH; Vasoo S; Li SC; Thumboo J
    J Rheumatol; 2003 Oct; 30(10):2268-74. PubMed ID: 14528528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population.
    Franks P; Lubetkin EI; Gold MR; Tancredi DJ
    Med Care; 2003 Nov; 41(11):1277-83. PubMed ID: 14583690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey.
    Luo N; Wang P; Fu AZ; Johnson JA; Coons SJ
    Med Care; 2012 Jul; 50(7):627-32. PubMed ID: 22456112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese Population Norms of EQ-5D-5L and Health Utilities Index Mark 3: Disutility Catalog by Disease and Symptom in Community Settings.
    Shiroiwa T; Noto S; Fukuda T
    Value Health; 2021 Aug; 24(8):1193-1202. PubMed ID: 34372985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of HUI2 and HUI3 utility scores in Alzheimer's disease.
    Neumann PJ; Sandberg EA; Araki SS; Kuntz KM; Feeny D; Weinstein MC
    Med Decis Making; 2000; 20(4):413-22. PubMed ID: 11059474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the HUI3 and the EQ-5D-3L in a nursing home setting.
    Lung T; Howard K; Etherton-Beer C; Sim M; Lewin G; Arendts G
    PLoS One; 2017; 12(2):e0172796. PubMed ID: 28234983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of generic health-related quality of life measures in stroke.
    Pickard AS; Johnson JA; Feeny DH
    Qual Life Res; 2005 Feb; 14(1):207-19. PubMed ID: 15789955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease.
    Davison SN; Jhangri GS; Feeny DH
    Qual Life Res; 2008 Aug; 17(6):933-42. PubMed ID: 18543076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.
    Maddigan SL; Feeny DH; Johnson JA;
    Med Decis Making; 2003; 23(6):489-501. PubMed ID: 14672109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.